A new study suggests that Gencor Pacific’s Levagen+ Palmitoylethanolamide (PEA) ingredient may alleviate symptoms of seasonal allergies as shown by a reduction in histamine and inflammatory markers despite a strong placebo effect.
The use of palmitoylethanolamide (PEA) has been shown to relieve severe headache faster than the pharmaceutical drug ibuprofen, according to a RCT conducted in Australia.
An ingredient commonly isolated from soybeans, peanuts, and egg yolks, has been shown in a recent review to act in similar pathways as cannabidiol (CBD), with researchers highlighting that it was a safer and legally recognised alternative.
Palmitoylethanolamide (PEA) has been shown to relieve pain and inflammation across several conditions such as migraine, menstrual cramp, joint and muscle pain, says a new review.